Furthermore, the sequential analysis of serial samples at multiple time points of the disease course, in two different series of patients with myeloid malignancies, showed that SETBP1 mutations were absent at the time of initial presentation while increasing in allele frequencies by time (49, 50). Here, SETBP1 is linked to myeloid neoplasm.